Sociedad Americana de Hirudoterapia

Modified method of scalp fixation promotes survival of complete scalp avulsion replantation

Case report published in Clin Case Rep (2024)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportEnsayos clínicosXu et al. · Clinical case reports, 2024

Abstract

A complete scalp avulsion injury is rare but extremely challenging to treat. Because of the dense blood vessel bundles in the scalp, replantation failure may occur if there is a subcutaneous hematoma. The method of scalp fixation is crucial for replantation to be successful. We successfully treated a total scalp avulsion injury using a modified scalp fixation method, coupled with microsurgical anastomosis, to avoid subcutaneous hematoma effectively and achieved a satisfactory outcome with a follow-up of 9 years postoperatively.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Resumen

Modified scalp-fixation technique promoting survival of complete scalp-avulsion replantation.

Por qué esto importa para la hirudoterapia

This article reports successful complete scalp avulsion replantation using a modified scalp fixation method combined with microsurgical anastomosis, aimed at preventing subcutaneous hematoma, with satisfactory outcomes at 9-year follow-up. While scalp replantation and microsurgical reconstruction are clinical contexts where leech therapy has occasionally been used for venous congestion management, this abstract makes no mention of leeches, hirudotherapy, or any leech-derived intervention. The study is a single case report focused on a technical modification of scalp fixation to avoid hematoma formation. No defensible connection to leech therapy, the leech secretome, or hirudin-based anticoagulation can be drawn from the abstract provided.

Citación

Modified method of scalp fixation promotes survival of complete scalp avulsion replantation.

Xu et al. · Clinical case reports, 2024

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.